Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Dulcy Wolverton

Concepts (98)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Mammography
12
2025
175
1.020
Why?
Breast Neoplasms
16
2025
2418
0.600
Why?
Comprehension
3
2025
175
0.400
Why?
Health Literacy
2
2024
183
0.320
Why?
Carcinoma, Intraductal, Noninfiltrating
3
2017
61
0.270
Why?
Communication
2
2023
980
0.230
Why?
Internet
2
2025
660
0.200
Why?
Chemotherapy, Adjuvant
3
2021
429
0.190
Why?
Patients
1
2023
183
0.170
Why?
Image Enhancement
2
2021
198
0.170
Why?
Radiology
2
2021
175
0.150
Why?
Neoadjuvant Therapy
2
2021
475
0.150
Why?
Mastectomy
2
2020
189
0.150
Why?
Delayed Diagnosis
1
2020
102
0.150
Why?
Contrast Media
2
2021
493
0.150
Why?
Patient Education as Topic
1
2024
770
0.140
Why?
Magnetic Resonance Imaging
5
2021
3926
0.140
Why?
Early Detection of Cancer
1
2023
506
0.130
Why?
Patient Care Management
1
2017
54
0.130
Why?
Aromatase Inhibitors
1
2017
81
0.120
Why?
Breast
2
2021
155
0.090
Why?
Aged
9
2025
26432
0.080
Why?
Middle Aged
12
2025
36619
0.070
Why?
Breast Diseases
2
2000
22
0.070
Why?
Receptors, Estrogen
1
2011
406
0.070
Why?
Humans
22
2025
146342
0.060
Why?
Female
17
2025
79499
0.060
Why?
Fibroadenoma
1
2005
2
0.060
Why?
Phyllodes Tumor
1
2005
2
0.060
Why?
Adult
9
2025
41087
0.060
Why?
Carcinoma, Ductal
1
2005
10
0.060
Why?
Surveys and Questionnaires
3
2024
6073
0.060
Why?
Spectrum Analysis
1
2005
85
0.050
Why?
Patient Portals
1
2024
52
0.050
Why?
Genetic Carrier Screening
1
2002
31
0.050
Why?
Neoplasms
1
2018
2954
0.050
Why?
BRCA2 Protein
1
2002
69
0.040
Why?
BRCA1 Protein
1
2002
84
0.040
Why?
Patient Navigation
1
2024
126
0.040
Why?
Germ-Line Mutation
1
2002
180
0.040
Why?
Electronics
1
2021
65
0.040
Why?
Specialization
1
2002
137
0.040
Why?
Interviews as Topic
1
2025
930
0.040
Why?
Medicine
1
2002
127
0.040
Why?
Radiographic Image Enhancement
1
2000
57
0.040
Why?
Neoplasm Staging
3
2017
1488
0.040
Why?
Patient Participation
1
2024
457
0.040
Why?
Medical Oncology
1
2023
345
0.040
Why?
Educational Status
1
2022
466
0.040
Why?
Feasibility Studies
1
2024
1135
0.040
Why?
Family Practice
1
2023
422
0.040
Why?
Biopsy
2
2017
1075
0.030
Why?
Image Processing, Computer-Assisted
1
2002
778
0.030
Why?
Patient-Centered Care
1
2022
553
0.030
Why?
Health Personnel
1
2023
754
0.030
Why?
Cohort Studies
2
2021
6077
0.030
Why?
Neoplasm Grading
1
2017
313
0.030
Why?
Electronic Health Records
1
2024
1210
0.030
Why?
Databases, Factual
2
2018
1493
0.030
Why?
Qualitative Research
1
2023
1734
0.030
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2005
1998
0.030
Why?
Radiographic Image Interpretation, Computer-Assisted
1
1996
121
0.030
Why?
Referral and Consultation
1
2021
881
0.030
Why?
Treatment Outcome
3
2021
11821
0.030
Why?
Calcinosis
1
1996
231
0.030
Why?
Medicare
1
2020
920
0.030
Why?
Clinical Competence
1
2002
1272
0.030
Why?
Prognosis
2
2017
4351
0.020
Why?
Software
1
2018
676
0.020
Why?
Biopsy, Needle
2
2005
183
0.020
Why?
Mass Screening
1
2000
1307
0.020
Why?
Immunohistochemistry
2
2006
1712
0.020
Why?
Diagnosis, Differential
3
2002
1503
0.020
Why?
Aged, 80 and over
2
2005
8391
0.020
Why?
Retrospective Studies
2
2021
17438
0.020
Why?
Combined Modality Therapy
1
2011
1271
0.020
Why?
ROC Curve
2
2002
617
0.020
Why?
Sensitivity and Specificity
2
2005
1998
0.020
Why?
Antigens, CD34
1
2006
89
0.020
Why?
Antigens, Differentiation, Myelomonocytic
1
2006
66
0.010
Why?
Ki-67 Antigen
1
2006
120
0.010
Why?
Subtraction Technique
1
2005
26
0.010
Why?
Gadolinium DTPA
1
2005
70
0.010
Why?
Lasers
1
2005
127
0.010
Why?
Young Adult
1
2021
14330
0.010
Why?
Radiography
1
2006
861
0.010
Why?
Prospective Studies
1
1996
8123
0.010
Why?
Antigens, CD
1
2006
560
0.010
Why?
United States
1
2020
16136
0.010
Why?
Follow-Up Studies
1
2011
5439
0.010
Why?
Biomarkers, Tumor
1
2006
1339
0.010
Why?
Physical Examination
1
2000
237
0.010
Why?
Reproducibility of Results
1
2005
3416
0.010
Why?
Inflammation
1
2006
2919
0.010
Why?
Algorithms
1
2002
1849
0.010
Why?
Genetic Predisposition to Disease
1
2002
2488
0.010
Why?
Risk Factors
1
2002
10921
0.000
Why?
Adolescent
1
2005
22557
0.000
Why?
Wolverton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)